BioVie Announces Promising Results from Phase 2 of the ADDRESS-LC Trial
BioVie announced promising results from the ADDRESS-LC trial assessing the potential impact of the drug bezisterim on cognitive impairment/brain fog and fatigue in people with Long Covid. Solve fought for […]